Literature DB >> 8114783

Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship.

S H Horowitz1, H Schmalbruch.   

Abstract

A large family is described with an autosomal dominant distal myopathy, the nature of which prompts the reevaluation of current classifications of these disorders. The disease begins in early to middle adulthood with gait disturbance due to distal leg weakness, and progresses over 5-10 years to involve all extremities, as well as bulbar, respiratory, and facial muscles. There is frequent cardiac involvement, manifest by arrhythmias, conduction blocks, and congestive failure, resulting in premature demise. On electromyography there is prominent spontaneous activity, short duration motor unit potentials, and polyphasia. Muscle biopsies from multiple family members at different stages of the disease are characterized by desmin storage and autophagocytosis. This distal myopathy differs from other phenotypically similar disorders in its rapidity of progression, fatal course and pathologic features. The role and specificity of excessive desmin accumulation in this and other myopathic and cardiac disorders are unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114783     DOI: 10.1002/mus.880170204

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

Review 1.  Desmin cytoskeleton in healthy and failing heart.

Authors:  Y Capetanaki
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 2.  Respiratory involvement in inherited primary muscle conditions.

Authors:  N Shahrizaila; W J M Kinnear; A J Wills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

3.  Distribution and organization of desmin in cultured adult cardiac muscle cells: reflection on function.

Authors:  A C Nag; S K Huffaker
Journal:  J Muscle Res Cell Motil       Date:  1998-11       Impact factor: 2.698

4.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  Desmin myopathy with cardiomyopathy.

Authors:  C H Cameron; M Mirakhur; I V Allen
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy.

Authors:  Anna Kaminska; Sergei V Strelkov; Bertrand Goudeau; Montse Olivé; Ayush Dagvadorj; Anna Fidzianska; Monique Simon-Casteras; Alexey Shatunov; Marinos C Dalakas; Isidro Ferrer; Hubert Kwiecinski; Patrick Vicart; Lev G Goldfarb
Journal:  Hum Genet       Date:  2003-11-27       Impact factor: 4.132

7.  Cytoplasmic body myopathy: familial cases with accumulation of desmin and dystrophin. An immunohistochemical, immunoelectron microscopic and biochemical study.

Authors:  A Caron; F Viader; B Lechevalier; F Chapon
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  A novel autosomal dominant inclusion body myopathy linked to 7q22.1-31.1.

Authors:  Yan Lu; Xingang Li; Min Wang; Xin Li; Feng Zhang; Yun Li; Meng Zhang; Yuwei Da; Jun Yu; Jianping Jia
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Two recurrent mutations are associated with GNE myopathy in the North of Britain.

Authors:  Amina Chaouch; Kathryn M Brennan; Judith Hudson; Cheryl Longman; John McConville; Patrick J Morrison; Maria E Farrugia; Richard Petty; Willie Stewart; Fiona Norwood; Rita Horvath; Patrick F Chinnery; Donald Costigan; John Winer; Tuomo Polvikoski; Estelle Healy; Anna Sarkozy; Teresinha Evangelista; Oksana Pogoryelova; Michelle Eagle; Kate Bushby; Volker Straub; Hanns Lochmüller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-02       Impact factor: 10.154

10.  Disruption of muscle architecture and myocardial degeneration in mice lacking desmin.

Authors:  D J Milner; G Weitzer; D Tran; A Bradley; Y Capetanaki
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.